US Launches Inquiry Into German Drug Pricing Rules, Raising Tariff Threat
The United States has initiated a formal investigation into Germany's pharmaceutical pricing regulations, with potential tariffs looming. The probe could reshape global drug pricing dynamics and impact healthcare costs across trading partners.